CCA
FOLD

Cygnus Capital Advisors’s Amicus Therapeutics FOLD Stock Holding History

Cygnus Capital Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,082
Closed -$59K – 82
2026
Q1 		$59K Hold
4,082
– – 0.04% 69
2025
Q4 		$58K Buy
+4,082
New +$40.1K 0.04% 64

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cygnus Capital Advisors's FOLD Position: Q2 2026 in Review

Cygnus Capital Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 4,082 shares — an estimated $59K sold.

Cygnus Capital Advisors first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $59K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Cygnus Capital Advisors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Cygnus Capital Advisors sold 4,082 Amicus Therapeutics shares in Q2 2026, an estimated $59K.
  • Cygnus Capital Advisors first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Cygnus Capital Advisors's Amicus Therapeutics position peaked at $59K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Cygnus Capital Advisors's 13F filing for Q2 2026, filed 3 Sep 2026.